Loading...
XJPX4896
Market cap49mUSD
Jan 17, Last price  
661.00JPY
1D
0.30%
1Q
-13.82%
IPO
-23.32%
Name

K Pharma Inc

Chart & Performance

D1W1MN
XJPX:4896 chart
P/E
29.47
P/S
7.67
EPS
22.43
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
1.00b
001,000,000,000
Net income
260m
P
-228,718,000-392,427,000260,330,000
CFO
454m
P
-196,320,000-363,482,000454,425,000

Profile

K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is based in Minato, Japan.
IPO date
Oct 17, 2023
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFY
2023‑122022‑122021‑12
Income
Revenues
1,000,000
 
Cost of revenue
90,000
163,971
Unusual Expense (Income)
NOPBT
910,000
(163,971)
NOPBT Margin
91.00%
Operating Taxes
40,746
1,900
Tax Rate
4.48%
NOPAT
869,254
(165,871)
Net income
260,330
-166.34%
(392,427)
71.58%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,496,325
1,544,375
BB yield
-17.91%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
30,654
4,620
Net debt
(3,266,408)
(1,336,847)
Cash flow
Cash from operating activities
454,425
(363,482)
CAPEX
(9,803)
(29,958)
Cash from investing activities
(11,099)
(32,737)
Cash from financing activities
1,486,235
1,544,285
FCF
869,652
(166,269)
Balance
Cash
3,266,408
1,336,847
Long term investments
Excess cash
3,216,408
1,336,847
Stockholders' equity
101,431
361,564
Invested Capital
3,033,991
977,420
ROIC
43.34%
ROCE
29.02%
EV
Common stock shares outstanding
11,605
9,331
Price
720.00
 
Market cap
8,355,312
 
EV
5,088,904
EBITDA
910,000
(163,971)
EV/EBITDA
5.59
Interest
11,849
Interest/NOPBT
1.30%